The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19

The coronavirus disease 2019 (COVID-19) pandemic has caused significant morbidity and mortality on a global scale. The etiologic agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), initiates host cell entry when its spike protein (S) binds to its receptor, angiotensin-converting enz...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Kun, Meyerholz, David K., Bartlett, Jennifer A., McCray, Paul B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406266/
https://www.ncbi.nlm.nih.gov/pubmed/34340553
http://dx.doi.org/10.1128/mBio.00970-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406266/
https://www.ncbi.nlm.nih.gov/pubmed/34340553
http://dx.doi.org/10.1128/mBio.00970-21

Ejemplares similares